HEMGENIX
Active substance: etranacogene dezaparvovec
KIT · etranacogene dezaparvovec
United StatesActive
Marketing holder: CSL Behring
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-982a-791c-9567-512a52bdf35e,01a1208c-9886-73ea-a4e0-cd73e7b92337,01a1208c-98c1-7205-80d5-2027e6c0ba11,01a1208c-9bd6-75f4-b2c8-2e8fe6259c2c,01a1208d-7b6c-7c49-887e-0095104b2ad9;count=39 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 0053-0150
- Registration status
- Active
- Dispensing
- Prescription only
Sources
- product · openFDA NDC · 0053-0150 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0053-0150 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0053-0150 · Verified 2026-10-09 · open in source